Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 4Thoracic 1Gynecologic 1Gastrointestinal 1

Conditions

Lung Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Thymoma 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Pancreatic Neoplasms 1Mesothelioma, Malignant 1Mesothelioma 1Liver Neoplasms 1Kidney Neoplasms 1Esophageal Neoplasms 1Carcinoma, Renal Cell 1Breast Neoplasms 1

Interventions

X-Rays 4Phantoms, Imaging 4Cyclophosphamide 4fludarabine 3Specimen Handling 3Melphalan 3Magnetic Resonance Spectroscopy 3ulixertinib 2tipifarnib 2tazemetostat 2talazoparib 2selpercatinib 2palbociclib 2ivosidenib 2Vemurafenib 2Temozolomide 2Sirolimus 2Nuclear Medicine Department, Hospital 2Nivolumab 2LY3023414 2Granulocyte Colony-Stimulating Factor 2Busulfan 2regorafenib 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1omburtamab I-131 1olaparib 1larotrectinib 1irinotecan sucrosofate 1fludarabine phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Ewing × FANG vaccine × Gastrointestinal × Clear all
NCT01061840 2022-03-15

Trial of Bi-shRNA-furin and GMCSF Augmented Autologous Tumor Cell Vaccine for Advanced Cancer

Gradalis, Inc.

Phase 1 Completed
100 enrolled
GastrointestinalSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Liver Neoplasms, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡